Skip to main content
SpringerLink
Log in

Lyme disease vaccine: a tick for prevention

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. Lyme disease: United States, 1996. MMWR 1997; 46(23): 531–5

    Google Scholar 

  2. Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999 Jun 4; 48 Suppl. RR-7: 1-26

  3. Onrust SV, Goa KL. Adjuvanted Lyme disease vaccine: a review of its use in the management of Lyme disease. Drugs 2000 Feb; 59(2): 281–299

    Article  PubMed  CAS  Google Scholar 

  4. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface lipoprotein A with adjuvant. N Eng J Med 1998 Jul 23; 339: 209–215

    Article  CAS  Google Scholar 

  5. Van Hoecke C, Lebacq E, Beran J, et al. Alternative vaccination schedules (0, 1 and 6 months versus 0, 1 and 12 months) for a recombinant OspA Lyme disease vaccine. Clin Infect Dis 1999 Jun; 28: 1260–4

    Article  PubMed  Google Scholar 

  6. Feder Jr HM, Beran J, Van Hoecke C, et al. Immunogenicity of recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children. J Pediatr 1999; 135: 575–9

    Article  PubMed  CAS  Google Scholar 

  7. Beran J, Dieussaert I, Van Hoecke C, et al. Reactogenicity and immunogenicity of LYMErix, the Lyme disease vaccine, in healthy children aged 2–5 years [abstract no. P219]. Eighth International Conference on Lyme borreliosis and other emerging tick-borne diseases: 1999 Jun 20–24; Munich: 60

    Google Scholar 

  8. Sigal LH. Lyme arthritis: lessons learned and to be learned. Arthritis Rheum 1999 Sep; 42(9); 1809–12

    Article  PubMed  CAS  Google Scholar 

  9. Meltzer MI, Dennis DT, Orloski KA. The cost effectiveness of vaccinating against Lyme disease. Emerg Infect Dis 1999 May–Jun; 5(3): 321–8

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyme disease vaccine: a tick for prevention. Drugs Ther. Perspect 16, 1–4 (2000). https://doi.org/10.2165/00042310-200016100-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200016100-00001

Keywords

Search

Navigation